Why World NET Cancer Day matters?
Neuroendocrine cancer (NETs) is frequently misdiagnosed and early detection is key. 58% of patients have advanced stage neuroendocrine cancer by the time they are correctly diagnosed, as shown in the Global NET Patient Survey – a collaborative effort of INCA and Novartis. There is currently no cure for the majority of patients. Frequently misdiagnosed with conditions such as: anxiety, menopause, Irritable Bowel Syndrome (IBS), asthma or diabetes, NETs require greater awareness amongst the community and medical professions.
Raising awareness about NETs with the public and medical community is a key goal for INCA and its members around the world, and NET Cancer Day offers a platform to speak in a united and stronger voice.